The blood glucose level rose both in wild-type (WT) and Nlrc4-/-mice one week after STZ treatment (Fig 2A) and hyperglycemia persisted during the 8-week period (Fig 2A). The gene discussed is NLRC4; the disease is Hyperglycemia.